FASANO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 17.278
EU - Europa 9.335
AS - Asia 4.300
SA - Sud America 472
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 11
Totale 31.469
Nazione #
US - Stati Uniti d'America 17.125
IT - Italia 4.397
UA - Ucraina 1.479
SG - Singapore 1.443
DE - Germania 835
SE - Svezia 758
CN - Cina 723
TR - Turchia 713
VN - Vietnam 579
HK - Hong Kong 569
FI - Finlandia 450
GB - Regno Unito 421
BR - Brasile 395
IE - Irlanda 388
RU - Federazione Russa 216
FR - Francia 106
CA - Canada 77
IN - India 71
MX - Messico 64
JP - Giappone 63
BE - Belgio 49
CZ - Repubblica Ceca 39
ES - Italia 39
PL - Polonia 38
NL - Olanda 32
BD - Bangladesh 31
AR - Argentina 26
ZA - Sudafrica 26
KR - Corea 19
EU - Europa 18
AT - Austria 13
PE - Perù 13
PK - Pakistan 13
IQ - Iraq 11
LT - Lituania 10
CO - Colombia 9
EC - Ecuador 9
CH - Svizzera 8
RO - Romania 8
AU - Australia 7
IL - Israele 7
PT - Portogallo 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
DK - Danimarca 6
EG - Egitto 6
ID - Indonesia 6
HR - Croazia 5
HU - Ungheria 5
NP - Nepal 5
TN - Tunisia 5
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
IR - Iran 4
JO - Giordania 4
MA - Marocco 4
MY - Malesia 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
DZ - Algeria 3
KE - Kenya 3
OM - Oman 3
SI - Slovenia 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
CL - Cile 2
JM - Giamaica 2
KZ - Kazakistan 2
NI - Nicaragua 2
NO - Norvegia 2
PH - Filippine 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 31.467
Città #
Milan 2.914
Fairfield 2.486
Woodbridge 1.474
Ashburn 1.413
Chandler 1.265
Jacksonville 1.139
Seattle 1.020
Houston 1.002
Cambridge 884
Wilmington 857
Singapore 804
Ann Arbor 624
Hong Kong 568
Dearborn 459
Princeton 406
Dublin 377
Dallas 368
Nyköping 335
Izmir 329
Boardman 277
Beijing 262
Rome 246
Dong Ket 240
Como 229
Chicago 198
Munich 180
The Dalles 172
San Mateo 149
Los Angeles 127
New York 118
San Diego 110
Ogden 78
London 68
Helsinki 67
Santa Clara 62
Tokyo 58
São Paulo 54
Hefei 52
Brussels 49
Ho Chi Minh City 38
Buffalo 37
Kunming 36
Warsaw 36
Denver 35
Salt Lake City 35
Turku 35
Montreal 34
Washington 34
Verona 33
Nanjing 31
Mexico City 30
Poplar 30
Falls Church 29
Düsseldorf 27
Nanchang 27
Orem 27
Stockholm 27
Guangzhou 26
Phoenix 25
Atlanta 24
Brooklyn 24
Council Bluffs 24
Paris 23
Olomouc 22
Amsterdam 21
Norwalk 21
Ponte Lambro 21
Chennai 20
Hanoi 20
Jinan 19
Curitiba 18
Johannesburg 18
Brno 17
Elk Grove Village 17
Redmond 17
San Francisco 17
Varese 17
Berlin 16
Edinburgh 16
Boston 15
Cavaria con Premezzo 15
Frankfurt am Main 15
Shenyang 15
Tampa 15
Columbus 13
Manchester 12
Redwood City 12
Toronto 12
Casorezzo 11
Chiswick 11
Detroit 11
Philadelphia 11
Pune 11
Hounslow 10
Kilburn 10
Kocaeli 10
Naples 10
New Bedfont 10
Pittsburgh 10
Prescot 10
Totale 22.793
Nome #
Experimental setup for the identification of mitochondrial protease substrates by shotgun and top-down proteomics 391
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment 349
Dopamine induces mitochondrial depolarization without activating PINK1-mediated mitophagy 268
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 253
Mitochondrial Proteins in the Development of Parkinson’s Disease 240
Flavonoid binding to human serum albumin. 238
A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1 238
Cellular models to investigate biochemical pathways in Parkinson's disease 231
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 229
Human serum albumin: from bench to bedside. 227
Systems biology analysis of the proteomic alterations induced by MPP+, a parkinson's disease-related mitochondrial toxin 223
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 222
Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding. 220
Drugs modulate allosterically heme-fe-recognition by human serum albumin and heme-fe-mediated reactivity 218
Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin. 217
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin. 216
Allostery in a monomeric protein: the case of human serum albumin. 212
Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma 212
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. 210
Ibuprofen and warfarin modulate allosterically ferrous human serum heme-albumin nitrosylation. 210
Sequence analysis of serum albumins reveals the molecular evolution of ligand recognition properties. 210
O2-mediated oxidation of ferrous nitrosylated human serum heme-albumin is limited by nitrogen monoxide dissociation. 203
All-trans-retinoic acid and retinol binding to the FA1 site of human serum albumin competitively inhibits heme-Fe(III) association 202
Verification of a parkinsons disease protein signature in T-lymphocytes by multiple reaction monitoring 200
H-1 NMR relaxometric characterization of bovine lactoferrin 200
Exploring the mitochondrial degradome by the TAILS proteomics approach in a cellular model of Parkinson's disease 195
Allosteric modulation of drug binding to human serum albumin 194
Proteomics as a tool to investigate cell models for dopamine toxicity 194
Thermodynamic analysis of hydration in human serum heme-albumin. 193
Reductive nitrosylation of ferric human serum heme-albumin. 191
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease 191
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration 189
Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover 189
Towards a functional definition of the mitochondrial human proteome 189
Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin - an optical and NMR spectroscopic investigation 187
Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress 187
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease 187
Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis 187
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 186
Proteomics and renaissance: accounts of the V Italian Proteomics Association Congress, Florence 2010. 186
Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin 185
Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin 184
Heme binding to albuminoid proteins is the result of recent evolution 184
Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin 184
Systems biology analysis of the proteomic alterations in Parkinson's disease: Common and disease-specific pathways 183
A systems biology-led insight into the role of the proteome in neurodegenerative diseases 182
1H NMR RELAXOMETRIC AND OPTICAL ABSORBANCE CHARACTERIZAZION OF THE INTERACTION OF MANGANESE PORPHYRINS WITH HUMAN SERUM ALBUMIN 181
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells 181
Mitochondrial alterations in Parkinson's disease human samples and cellular models 181
Demonstration of fibrinogen-FcRn binding at acidic pH by means of Fluorescence Correlation Spectroscopy 181
PARAMAGNETIC GD-III-FE-III HETEROBIMETALLIC COMPLEXES OF DTPA-BIS-SALICYLAMIDE 178
AN NMR-STUDY OF THE INTERACTION BETWEEN MELANIN FREE ACID AND MN2+ IONS AS A MODEL TO MIMIC THE ENHANCED PROTON RELAXATION RATES IN MELANOTIC MELANOMA 178
Method for the in vitro diagnosis of parkinson's disease 178
Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies 175
Isolation and C-13-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease 174
Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites. 174
Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties 174
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies 174
Proteome analysis of human substantia nigra in Parkinson's disease 173
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 173
Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin 172
Integrative proteomics: perspective in complex system interpretation. 170
Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage 170
Pseudo-enzymatic hydrolysis of 4-nitrophenyl myristate by human serum albumin. 169
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients 168
Cellular response to empty and palladium-conjugated amino-polystyrene nanospheres uptake: A proteomic study 167
SYNTHESIS AND CHARACTERIZATION OF A NOVEL DTPA-LIKE GADOLINIUM(III) COMPLEX - A POTENTIAL REAGENT FOR THE DETERMINATION OF GLYCATED PROTEINS BY WATER PROTON NMR RELAXATION MEASUREMENTS 165
Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin 165
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis 165
Diagnostic Salivary Tests for SARS-CoV-2 165
Digital and analogical reality in proteomics investigation 164
The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study. 164
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 164
1H-NMR relaxometric analysis of drug binding effects to global unfolding of human serum albumin. 163
Alpha-synuclein and Parkinson's disease: a proteomic view 163
Azide, cyanide, fluoride, imidazole and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative: A comparative study 162
Stabilization of the T-state of human hemoglobin by proflavine, an antiseptic drug 161
Prevention and modulation of aminoglycoside ototoxicity (Review) 161
H-1-NMR relaxometric study of pancreatic serine (pro)enzyme inhibition by a Gd(III) chelate bearing boronic functionalities 160
A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy 159
Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates 159
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin. 159
Saggio rapido per la diagnosi in vitro di infezione da SARS-CoV-2 in un fluido biologico 159
Mn(II) binding to human serum albumin: A (1)H-NMR relaxometric study. 159
EVIDENCE FOR A GLYCIDIC-LIPIDIC MATRIX IN HUMAN NEUROMELANIN, POTENTIALLY RESPONSIBLE FOR THE ENHANCED IRON SEQUESTERING ABILITY OF SUBSTANTIA-NIGRA 158
Sviluppo di un modello cellulare della disfunzione mitocondriale nella malattia di Parkinson nella linea cellulare SH-SY5Y in seguito a trattamento con dopamina o MPP+ ed analisi proteomica dei profili di espressione proteica dei mitocondri in modelli di patologie neurodegenerative. 158
Metodo per la diagnosi in vitro della malattia di Parkinson 157
Parkinson's disease plasma biomarkers: An automated literature analysis followed by experimental validation 157
Serum heme-albumin: an allosteric protein. 156
NMR-STUDIES OF MELANINS - CHARACTERIZATION OF A SOLUBLE MELANIN FREE ACID FROM SEPIA INK 155
The drug-dependent five- to six-coordination transition of the heme-Fe atom modulates allosterically human serum heme-albumin reactivity 155
Warfarin inhibits allosterically the reductive nitrosylation of ferric human serum heme-albumin 153
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells 151
Magnetic investigations of human mesencephalic neuromelanin 150
Saliva is a reliable tool to detect SARS-CoV-2 150
Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin. 149
Imatinib binding to human serum albumin modulates heme association and reactivity 149
METAL-ION CONTENT IN SEPIA-OFFICINALIS MELANIN 148
Reversible two-step unfolding of heme-human serum albumin: a H-1-NMR relaxometric and circular dichroism study 148
Unfolding of the loggerhead sea turtle (Caretta caretta) myoglobin: A H-1-NMR and electronic absorbance study 147
Totale 18.635
Categoria #
all - tutte 124.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.611 0 0 0 0 0 425 270 306 511 221 320 558
2021/20222.362 300 403 166 84 109 77 145 114 113 308 211 332
2022/20233.277 311 194 268 345 224 645 10 459 484 118 137 82
2023/20244.722 751 762 748 838 931 248 34 148 114 25 20 103
2024/20253.381 18 44 587 98 111 187 162 282 366 410 275 841
2025/20263.148 449 456 305 974 825 139 0 0 0 0 0 0
Totale 31.596